KZA 0.00% 8.0¢ kazia therapeutics limited

Priscilla Brastianos is the lead investigator for the Alliance...

  1. 856 Posts.
    lightbulb Created with Sketch. 356
    https://hotcopper.com.au/data/attachments/3828/3828557-abc87b42e0da5110b2e57a00c9defe1b.jpg

    Priscilla Brastianos is the lead investigator for the Alliance clinical trial ("Genetic Testing in Guiding Treatment for Patients With Brain Metastases"), which examines paxalisib and two other drugs on patients based upon genetic biomarkers.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.